Skip to content
AnalystLens

Exelixis 8-K Report, Corporate Update (Feb 21, 2025)

Reports
Other Events·Exhibits & Filings
Filing Date
Filed February 21, 2025
Period End
February 20, 2025
Security
EXEL
In the record · 2016–202610-K1110-Q358-K119

EXEL filed 11 annual reports (10-K), 35 quarterly reports (10-Q) and 119 current reports (8-K) between 2016 and 2026.

  1. Material agreement8-K · Jul ’17Jul ’17
  2. Material agreement8-K · Dec ’19Dec ’19
  3. Leadership change8-K · May ’22May ’22
  4. Leadership change8-K · May ’26May ’26

Summary

Summary of the 8-K filed February 21, 2025. Cited figures are marked; the original filing is the authoritative source.

Exelixis, Inc. (Nasdaq: EXEL) reported in this Form 8-K, filed February 21, 2025 for an event dated February 20, 2025, that its Board of Directors authorized the repurchase of up to an additional $500 milliona of its common stock before December 31, 2025.

The announcement is furnished as Exhibit 99.1 to the filing and is made under Item 8.01 (Other Events). According to the accompanying press release, Exelixis plans to complete its currently ongoing $500 millionb stock repurchase program, announced in August 2024, in the second quarter of 2025, and to begin repurchases under the newly authorized program thereafter. The company states that the February 2025 program is the fourth such program undertaken since March 2023, and that it has returned over $1.2 billion to shareholders through these programs as of the end of fiscal year 2024.

The press release says repurchases may be made through open market purchases, block trades, accelerated share repurchase transactions, exchange transactions, or a combination of these. Timing and amount will depend on capital needs, alternative investment opportunities, the stock price, and general market conditions. The filing also notes that the company's Annual Report on Form 10-K was filed with the SEC on February 11, 2025.

Key Highlights

  1. Board authorized a new stock repurchase program of up to an additional $500 million of common stock, to be executed before December 31, 2025
  2. Exelixis expects to complete its current $500 million program (announced August 2024) in the second quarter of 2025, then begin the new program
  3. This is the fourth stock repurchase program the company has undertaken since March 2023
  4. Exelixis states it has returned over $1.2 billion to shareholders through these programs as of the end of fiscal year 2024
  5. Repurchases may be executed via open market purchases, block trades, accelerated share repurchases, exchange transactions, or combinations thereof
  6. Timing and size of repurchases depend on capital needs, alternative investment opportunities, stock price, and market conditions

Frequently Asked Questions

  1. How large is the newly authorized buyback?

    The Board authorized the repurchase of up to an additional $500 million of Exelixis common stock before December 31, 2025.

  2. When will the new repurchase program begin?

    Exelixis plans to complete its currently ongoing $500 million program, announced in August 2024, in the second quarter of 2025, and to commence repurchases under the new program thereafter.

  3. How will the company execute the repurchases?

    Per the press release, repurchases may be made from time to time through open market purchases, block trades, accelerated share repurchase transactions, exchange transactions, or any combination of these methods.

  4. What factors will influence the timing and amount of repurchases?

    The company cites ongoing assessments of the business's capital needs, alternative investment opportunities, the market price of its common stock, and general market conditions.

  5. How much has Exelixis returned to shareholders through buybacks?

    The company states it has returned over $1.2 billion to shareholders through its stock repurchase programs as of the end of fiscal year 2024.